Muscle-specific overexpression of heparin-binding epidermal growth factor-like growth factor increases peripheral glucose disposal and insulin sensitivity

Endocrinology

Volumn 150, Issue 6, 2009, Pages 2683-2691

  Fukatsu, Yasuhide ^a   Noguchi, Tetsuya ^a   Hosooka, Tetsuya ^a,g   Ogura, Takeshi ^a   Kotani, Ko ^a   Abe, Takaya ^b   Shibakusa, Tetsuro ^c   Inoue, Kazuo ^c   Sakai, Mashito ^a   Tobimatsu, Kazutoshi ^a   Inagaki, Kenjiro ^a   Yoshioka, Toyo ^a   Matsuo, Masahiro ^c   Nakae, Jun ^a   Matsuki, Yasushi ^d   Hiramatsu, Ryuji ^d   Kaku, Kohei ^e   Okamura, Hitoshi ^c   Fushiki, Tohru ^c   Kasuga, Masato ^a,f  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^e KAWASAKI MEDICAL SCHOOL   (Japan)

^f NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GLUCOSE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INSULIN; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROCNEMIUS MUSCLE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; INSULIN SENSITIVITY; MALE; MOUSE; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY LIVER; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; OBESITY; PHYSICAL CONDITIONING, ANIMAL; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 66649100810     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1647     Document Type: Article

References (48)

1. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ 2001 Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218-1227
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM 2002 Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
3. Maiorana A, O'Driscoll G, Goodman C, Taylor R, Green D 2002 Combined aerobic and resistance exercise improves glycemic control and fitness in type 2 diabetes. Diabetes Res Clin Pract 56:115-123
4. Henriksen EJ 2002 Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93:788-796 (Pubitemid 34810247)
5. Holloszy JO 2005 Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol 99:338-343
6. Zierath JR 2002 Exercise training-induced changes in insulin signaling in skeletal muscle. J Appl Physiol 93:773-781 (Pubitemid 34810245)
7. Jessen N, Goodyear LJ 2005 Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 99:330-337
8. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, Meier CA, Bell DR, Kralli A, Giacobino JP, Dériaz O 2003 Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 52:2874-2881
9. Adamo ML, Farrar RP 2006 Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process. Ageing Res Rev 5:310-331
10. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M 1991 A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939
11. Raab G, Klagsbrun M 1997 Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:179-199
12. Ongusaha PP, Kwak JC, Zwible AJ, Macip S, Higashiyama S, Taniguchi N, Fang L, Lee SW 2004 HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res 64:5283-5290
13. Kiso S, Kawata S, Tamura S, Inui Y, Yoshida Y, Sawai Y, Umeki S, Ito N, Yamada A, Miyagawa J, Higashiyama S, Iwawaki T, Saito M, Taniguchi N, Matsuzawa Y, Kohno K 2003 Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 124:701-707
14. Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C, Yokota K, Nakamura M, Sayama K, Mekada E, Higashiyama S, Hashimoto K 2005 Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 118:2363-2370
15. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, Nanba D, Higashiyama S, Hori M, Klagsbrun M, Mekada E 2003 Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA 100:3221-3226
16. Jaynes JB, Johnson JE, Buskin JN, Gartside CL, Hauschka SD 1988 The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol Cell Biol 8:62-70
17. Ishihara K, Oyaizu S, Onuki K, Lim K, Fushiki T 2000 Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr 130:2990-2995
18. Nakae J, Cao Y, Daitoku H, Fukamizu A, Ogawa W, Yano Y, Hayashi Y 2006 The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest 116:2473-2483
19. Nakae J, Park BC, Accili D 1999 Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmann-insensitive pathway. J Biol Chem 274:15982-15985
20. Furuyama T, Kitayama K, Yamashita H, Mori N 2003 Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 375:365-371
21. Ogilvie RW, Feeback DL 1990 A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB and IIC. Stain Technol 65:231-241
22. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw 3rd EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ 2001 Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728-1731
23. Watson RT, Kanzaki M, Pessin JE 2004 Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25:177-204
24. Reynolds CM, Eguchi S, Frank GD, Motley ED 2002 Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension 39:525-529
25. Jin K, Mao XO, Del Rio Guerra G, Jin L, Greenberg DA 2005 Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3′-kinase and mitogen-activated protein kinase. J Neurosci Res 81:497-505
26. Mehta VB, Besner GE 2005 Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-κB activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway. J Immunol 175:1911-1918
27. Barthel A, Schmoll D, Unterman TG 2005 FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16:183-189
28. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412
29. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ 2004 The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403
30. Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N 1995 Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6:967-980
31. Iwamoto R, Mekada E 2000 Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 11:335-344
32. Zhu X, Lai C, Thomas S, Burden SJ 1995 Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J 14:5842-5848
33. LeBrasseur NK, Mizer KC, Parkington JD, Sawyer DB, Fielding RA 2005 The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training. Eur J Appl Physiol 94:371-375
34. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M 1997 Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16:1268-1278
35. Olayioye MA, Neve RM, Lane HA, Hynes NE 2000 The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19:3159-3167
36. LeBrasseur NK, Cote GM, Miller TA, Fielding RA, Sawyer DB 2003 Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Am J Physiol Cell Physiol 284:1149-1155
37. Sakamoto K, Hirshman MF, Aschenbach WG, Goodyear LJ 2002 Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277:11910-11917
38. Cantó C, Chibalin AV, Barnes BR, Glund S, Suárez E, Ryder JW, Palacín M, Zierath JR, Zorzano A, Gumà A 2006 Neuregulins mediate calcium-induced glucose transport during muscle contraction. J Biol Chem 281:21690-21697
39. Cleasby ME, Reinten TA, Cooney GJ, James DE, Kraegen EW 2007 Functional studies of Akt isoform specificity in skeletal muscle in vivo: maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 21:215-228
40. Kwon HS, Huang B, Unterman TG, Harris RA 2004 Protein kinase B-α inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 53:899-910
41. Holness MJ, Sugden MC 2003 Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans 31:1143-1151
42. Jeoung NH, Harris RA 2008 Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab 295:46-54
43. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD 2001 Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019
44. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ 2004 Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295-9304
45. Iwamoto R, Handa K, Mekada E 1999 Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J Biol Chem 274:25906-25912
46. Wellen KE, Hotamisligil GS 2005 Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119
47. McGarry JD, Mannaerts GP, Foster DW 1977 A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 60:265-270
48. Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR 1996 Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 98:2244-2250